JOANN NEGRON: Open Payments
NPI 1902893530 · KINGWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,218 in 51 payments from 13 companies in 2025. Trend: 2023 $698 · 2024 $727 · 2025 $1,218
Food & beverage: $1,218
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $227 |
| Teva Pharmaceuticals USA, Inc. | 4 | $170 |
| Alkermes, Inc. | 7 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $105 |
| E.R. Squibb & Sons, L.L.C. | 4 | $100 |
| ABBVIE INC. | 4 | $99 |
| Neurocrine BioSciences, Inc. | 5 | $88 |
| Lundbeck LLC | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Tris Pharma Inc | 2 | $44 |
Products named: CAPLYTA, REXULTI, ARISTADA, UZEDY, TRINTELLIX, COBENFY, VRAYLAR, INGREZZA.
Industry payments across TX — which companies pay providers there.
